lung cancer, lung cancer suspected metastatic lung tumor, metastatic lung tumor suspected
Conditions
Interventions
Indocyanine green 0.25mg/kg is injected into a peripheral vein.
Sponsors
Oncology, Immunology and Surgery, Nagoya City University, Graduate School of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients over 20 years old and under 90 years old in obtaining written informed consent. 2. Patients with lung cancer or metastatic lung tumor are considered as an indication of lung segmentectomy. 3. Patients with obtaining written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of side effects from ICG 2. Patients with iodine hypersensitivity 3. Women who are likely to be pregnant and possibly pregnant 4. Patients who are thought to be difficult to undergo thoracoscopic lung segmentectomy depending on the degree of tumor progression 5. Patients judged to be unable to tolerate general anesthesia, such as severe heart disease 6. Patients with infection requiring systemic treatment 7. Patients with fever at surgery 8. Patients who are complicated with psychosis or psychiatric symptoms and are considered difficult to participate in the study 9. Patients who can not obtain consent of transfusion 10. Clinicians decide to exclude from this trial in some reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Morbidity ratio and ratio of identification of segmental plane for ICG infrared thoracoscopic technique | — |
Secondary
| Measure | Time frame |
|---|---|
| Coincidence ratio of identification of segmental plane between anatomical method, inflation-deflation technique and ICG infrared thoracoscopic technique. | — |
Countries
Japan
Contacts
Public ContactHiroshi Haneda
Nagoya City University, Graduate School of Medical Sciences Oncology, Immunology and Surgery
Outcome results
None listed